Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Significance of liquid biopsy in glioblastoma - A review.

Klekner Á, Szivos L, Virga J, Árkosy P, Bognár L, Birkó Z, Nagy B.

J Biotechnol. 2019 Jun 10;298:82-87. doi: 10.1016/j.jbiotec.2019.04.011. Epub 2019 Apr 12.

PMID:
30986516
2.

Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.

Shang M, Ji JS, Song C, Gao BJ, Jin JG, Kuo WP, Kang H.

Methods Mol Biol. 2017;1660:1-14. doi: 10.1007/978-1-4939-7253-1_1. Review.

PMID:
28828643
3.

Emerging circulating biomarkers in glioblastoma: promises and challenges.

Touat M, Duran-Peña A, Alentorn A, Lacroix L, Massard C, Idbaih A.

Expert Rev Mol Diagn. 2015;15(10):1311-23. doi: 10.1586/14737159.2015.1087315. Review.

4.

The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.

Choi D, Montermini L, Kim DK, Meehan B, Roth FP, Rak J.

Mol Cell Proteomics. 2018 Oct;17(10):1948-1964. doi: 10.1074/mcp.RA118.000644. Epub 2018 Jul 13.

PMID:
30006486
5.

Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.

Mallawaaratchy DM, Hallal S, Russell B, Ly L, Ebrahimkhani S, Wei H, Christopherson RI, Buckland ME, Kaufman KL.

J Neurooncol. 2017 Jan;131(2):233-244. doi: 10.1007/s11060-016-2298-3. Epub 2016 Oct 21.

6.

Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.

Setti M, Osti D, Richichi C, Ortensi B, Del Bene M, Fornasari L, Beznoussenko G, Mironov A, Rappa G, Cuomo A, Faretta M, Bonaldi T, Lorico A, Pelicci G.

Oncotarget. 2015 Oct 13;6(31):31413-27. doi: 10.18632/oncotarget.5105.

7.

Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.

Iaccarino C, Orlandi E, Ruggeri F, Nicoli D, Torricelli F, Maggi M, Cerasti D, Pisanello A, Pedrazzi G, Froio E, Crafa P, D'Abbiero N, Michiara M, Ghadirpour R, Servadei F.

Clin Neurol Neurosurg. 2015 May;132:1-8. doi: 10.1016/j.clineuro.2015.01.029. Epub 2015 Feb 7.

PMID:
25723791
8.

Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.

de Vrij J, Maas SL, Kwappenberg KM, Schnoor R, Kleijn A, Dekker L, Luider TM, de Witte LD, Litjens M, van Strien ME, Hol EM, Kroonen J, Robe PA, Lamfers ML, Schilham MW, Broekman ML.

Int J Cancer. 2015 Oct 1;137(7):1630-42. doi: 10.1002/ijc.29521. Epub 2015 Apr 7.

9.

The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.

Hallal S, Ebrahimkhani S, Shivalingam B, Graeber MB, Kaufman KL, Buckland ME.

Brain Tumor Pathol. 2019 Apr;36(2):29-39. doi: 10.1007/s10014-019-00335-0. Epub 2019 Mar 11. Review.

PMID:
30859343
10.

STAT6 expression in glioblastoma promotes invasive growth.

Merk BC, Owens JL, Lopes MB, Silva CM, Hussaini IM.

BMC Cancer. 2011 May 20;11:184. doi: 10.1186/1471-2407-11-184.

11.

Glioblastoma extracellular vesicles: reservoirs of potential biomarkers.

Redzic JS, Ung TH, Graner MW.

Pharmgenomics Pers Med. 2014 Feb 13;7:65-77. doi: 10.2147/PGPM.S39768. eCollection 2014. Review.

12.

Liquid biopsy for brain tumors.

Shankar GM, Balaj L, Stott SL, Nahed B, Carter BS.

Expert Rev Mol Diagn. 2017 Oct;17(10):943-947. doi: 10.1080/14737159.2017.1374854. Epub 2017 Sep 6. Review.

13.

Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.

Figueroa JM, Skog J, Akers J, Li H, Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, LoGuidice L, Berghoff E, Parsa A, Liau L, Curry W, Cahill D, Bettegowda C, Lang FF, Chiocca EA, Henson J, Kim R, Breakefield X, Chen C, Messer K, Hochberg F, Carter BS.

Neuro Oncol. 2017 Oct 19;19(11):1494-1502. doi: 10.1093/neuonc/nox085.

14.

Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.

Oushy S, Hellwinkel JE, Wang M, Nguyen GJ, Gunaydin D, Harland TA, Anchordoquy TJ, Graner MW.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). pii: 20160477. doi: 10.1098/rstb.2016.0477.

15.

Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.

Simon T, Pinioti S, Schellenberger P, Rajeeve V, Wendler F, Cutillas PR, King A, Stebbing J, Giamas G.

Mol Cancer. 2018 Aug 31;17(1):132. doi: 10.1186/s12943-018-0878-x.

16.

Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients.

Santiago-Dieppa DR, Steinberg J, Gonda D, Cheung VJ, Carter BS, Chen CC.

Expert Rev Mol Diagn. 2014 Sep;14(7):819-25. doi: 10.1586/14737159.2014.943193. Review.

17.

Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?

Minciacchi VR, Zijlstra A, Rubin MA, Di Vizio D.

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):251-258. doi: 10.1038/pcan.2017.7. Epub 2017 Apr 4. Review.

18.

The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients.

Soler DC, Young AB, Cooper KD, Kerstetter-Fogle A, Barnholtz-Sloan JS, Gittleman H, McCormick TS, Sloan AE.

J Neurooncol. 2017 Aug;134(1):189-196. doi: 10.1007/s11060-017-2508-7. Epub 2017 May 27.

PMID:
28551851
19.

Extracellular Vesicles in Brain Tumor Progression.

D'Asti E, Chennakrishnaiah S, Lee TH, Rak J.

Cell Mol Neurobiol. 2016 Apr;36(3):383-407. doi: 10.1007/s10571-015-0296-1. Epub 2016 Mar 18. Review.

PMID:
26993504
20.

A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.

Konar SK, Bir SC, Maiti TK, Nanda A.

J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4. Review.

PMID:
27813458

Supplemental Content

Support Center